Carbamazepine
Showing 1 - 25 of 280
Healthy Trial (BI 1810631, Carbamazepine)
Not yet recruiting
- Healthy
- BI 1810631
- Carbamazepine
- (no location specified)
Sep 1, 2023
Healthy Participants Trial (Darigabat, Carbamazepine)
Not yet recruiting
- Healthy Participants
- Darigabat
- Carbamazepine
- (no location specified)
Apr 11, 2023
Autonomic Activity of Self-limiting Focal Epilepsy?
Active, not recruiting
- Epilepsy; Syndrome, Seizures of Localized Onset
- electroencephalogram
-
Merkez, Balikesi̇r, TurkeyBalıkesir University Medical Faculty
Nov 14, 2023
Healthy Participants Trial in Brussels (Vepdegestrant, Carbamazepine)
Not yet recruiting
- Healthy Participants
- Vepdegestrant
- Carbamazepine
-
Brussels, BelgiumPfizer Clinical Research Unit - Brussels
Aug 15, 2023
Focal Epilepsy Trial in Dhaka (Lamotrigine tablet, Carbamazepine-Containing Product in Oral Dose Form)
Enrolling by invitation
- Focal Epilepsy
- Lamotrigine tablet
- Carbamazepine-Containing Product in Oral Dose Form
-
Dhaka, BangladeshDhaka medical college
Feb 24, 2023
Healthy Volunteers Trial in Overland Park (Emraclidine, Itraconazole, Carbamazepine)
Recruiting
- Healthy Volunteers
- Emraclidine
- +3 more
-
Overland Park, KansasOverland Park, Kansas
Jul 20, 2023
Healthy Subjects Trial in Lenexa (DZD9008 and intraconazole, DZD9008 and carbamazepine)
Active, not recruiting
- Healthy Subjects
- DZD9008 and intraconazole
- DZD9008 and carbamazepine
-
Lenexa, KansasPharmaceutical Research Associates, Inc.
Jan 18, 2023
Parkinson Disease Trial in Madison (Tavapadon, Carbamazepine)
Active, not recruiting
- Parkinson Disease
- Tavapadon
- Carbamazepine
-
Madison, WisconsinMadison, Wisconsin
Jan 13, 2023
Healthy Trial in Neu-Ulm (Tepotinib Hydrochloride Hydrate, Carbamazepine)
Completed
- Healthy
- Tepotinib Hydrochloride Hydrate
- Carbamazepine
-
Neu-Ulm, GermanyNuvisan GmbH
Jun 5, 2022
Healthy Trial in Merksem (Erdafitinib, Carbamazepine)
Completed
- Healthy
- Erdafitinib
- Carbamazepine
-
Merksem, BelgiumClinical Pharmacology Unit
Jul 14, 2022
Healthy Subjects Trial in Lenexa (AZD4205 and carbamazepine, AZD4205 and itraconazole)
Recruiting
- Healthy Subjects
- AZD4205 and carbamazepine
- AZD4205 and itraconazole
-
Lenexa, KansasPharmaceutical Research Associates, Inc.
Aug 2, 2022
Pharmacoresistant Focal Epilepsies Trial in Paris (Stiripentol)
Recruiting
- Pharmacoresistant Focal Epilepsies
-
Paris, FranceCentre de Référence Epilepsies Rares / Centre Investigation Clin
Oct 13, 2022
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men Trial in Mannheim (Elinzanetant (BAY3427080), Midazolam,
Completed
- Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
- Elinzanetant (BAY3427080)
- +2 more
-
Mannheim, Baden-Württemberg, GermanyCRS Clinical-Research-Services Mannheim GmbH
Feb 24, 2022
Trigeminal Neuralgia Trial in Hangzhou (EA+ Carbamazepine, EA+Placebo, sham EA+Carbamazepine)
Completed
- Trigeminal Neuralgia
- EA+ Carbamazepine
- +3 more
-
Hangzhou, Zhejiang, Chinathe Third affiliated hospital of Zhejiang Chinese Medical univer
Sep 13, 2022
Trigeminal Neuralgia Trial in Rohtak (Oxcarbazepine, Carbamazepine)
Recruiting
- Trigeminal Neuralgia
- Oxcarbazepine
- Carbamazepine
-
Rohtak, Haryana, India
- +1 more
Oct 14, 2021
Healthy Participant Trial in New Haven (PF-07321332/ritonavir, Carbamazepine, PF 07321332/ritonavir)
Completed
- Healthy Participant
- PF-07321332/ritonavir
- +2 more
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Oct 18, 2021
Alpha-1-antitrypsin Deficiency, Liver Cirrhosis Trial in Saint Louis, Pittsburgh (Drug-Carbamazepine (Tegretol XR),
Terminated
- Alpha-1-antitrypsin Deficiency
- Liver Cirrhosis
- Drug-Carbamazepine (Tegretol XR)
- Carbamazepine (Tegretol XR) Placebo
-
Saint Louis, Missouri
- +2 more
Oct 7, 2021